⚪️ Polycystic ovary syndrome (PCOS) has been renamed Polyendocrine Metabolic Ovarian Syndrome (PMOS) following a global study in The Lancet. The new name reflects its multisystem nature, impacting endocrine, metabolic, reproductive, dermatological, and psychological health.

⚪️ The previous name was inaccurate as many patients don't have ovarian cysts, leading to delayed diagnoses, fragmented care, stigma, and missed early interventions for metabolic and cardiovascular risks.

⚪️ PMOS emphasizes the condition's hormonal and metabolic complexity, acknowledges cardiometabolic effects, and still includes ovaries without overemphasizing reproductive issues, aiming for earlier diagnosis, holistic care, reduced fertility stigma, and expanded research.

#PCOS #HealthNews #MedicalUpdate